SynthesisAmerican journal of hematology2025

Belantamab Mafodotin Plus Proteasome Inhibition Efficacy Versus Comparators in Early Relapsed Myeloma: A Systematic Review and Network Meta-Analysis.

Joshua Richter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.